Expert insights on medical device compliance, QMS best practices, and regulatory updates.
QA teams are quietly using ChatGPT to draft SOPs. Inspectors are noticing. The 4 compliance problems, the 5 questions to expect, and a defensible framework for AI-assisted document development.
AI can accelerate gap assessments, but generic tools introduce hallucination and audit trail risks. Here's a 5-point framework for using AI responsibly in compliance work.
CAPA topped FDA warning letter violations in FY2025. Learn the 3 red flags of ineffective CAPA and a root cause framework that actually prevents recurrence.
Document control violations account for 60%+ of FDA 483s. Learn the 5 critical mistakes that fail audits and how to fix them before your next inspection.
FDA warning letters for supplier control failures cost $2.3M average to fix. Check if your quality agreements meet 21 CFR 820.50 and ISO 13485.
CDER warning letters surged 50% in FY2025. Here are the supplier compliance findings that keep appearing in 483s, and what you can actually do about them.
The February 2, 2026 QMSR deadline has passed. Medical device manufacturers must now demonstrate full compliance. Learn what FDA inspectors are looking for and how to verify your transition.
